Evidence map›Paper›PMID 31601958›Full record

ArticleScientific reports2019

Noninvasive intravital high-resolution imaging of pancreatic neuroendocrine tumours.

Mirela Balan, Marta Trusohamn, Frank Chenfei Ning, Stefan Jacob, Kristian Pietras, Ulf Eriksson, Per-Olof Berggren, Daniel Nyqvist

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Boundary-Preserved Deep Denoising of Stochastic Resonance Enhanced Multiphoton Images.IEEE journal of translational engineering in health and medicine · 2022
    Article
  8. Review
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Mirela BalanDivision of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, 17165, Sweden.
Marta TrusohamnDivision of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, 17165, Sweden.
Frank Chenfei NingDivision of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, 17165, Sweden.
Stefan JacobThe Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Karolinska University Hospital L1, Stockholm, 17165, Sweden.
Kristian PietrasDivision of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, 22381, Sweden.ORCID http://orcid.org/0000-0001-6738-4705
Ulf ErikssonDivision of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, 17165, Sweden.ORCID http://orcid.org/0000-0002-4439-3980
Per-Olof BerggrenThe Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Karolinska University Hospital L1, Stockholm, 17165, Sweden.
Daniel NyqvistDivision of Vascular Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, 17165, Sweden. daniel.nyqvist@ki.se.ORCID http://orcid.org/0000-0002-6527-6716
Karolinska Institutet · SEKarolinska University Hospital · SELund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Preclinical trials of cancer drugs in animal models are important for drug development. The Rip1Tag2 (RT2) transgenic mouse, a model of pancreatic neuroendocrine tumours (PNET), has provided immense knowledge about PNET biology, although tumour progression occurs in a location inaccessible for real-time monitoring. To overcome this hurdle we have developed a novel platform for intravital 3D imaging of RT2 tumours to facilitate real-time studies of cancer progression. Pre-oncogenic islets retrieved from RT2 mice were implanted into the anterior chamber of the eye (ACE) of host mice, where they engrafted on the iris, recruited blood vessels and showed continuous growth. Noninvasive confocal and two-photon laser-scanning microscopy through the transparent cornea facilitated high-resolution imaging of tumour growth and angiogenesis. RT2 tumours in the ACE expanded up to 8-fold in size and shared hallmarks with tumours developing in situ in the pancreas. Genetically encoded fluorescent reporters enabled high-resolution imaging of stromal cells and tumour cell migration. Sunitinib treatment impaired RT2 tumour angiogenesis and growth, while overexpression of the vascular endothelial growth factor (VEGF)-B increased tumour angiogenesis though tumour growth was impaired. In conclusion, we present a novel platform for intravital high-resolution and 3D imaging of PNET biology and cancer drug assessment.

Indexed as

AnimalsAntineoplastic AgentsBacterial ProteinsDisease Models, AnimalDisease ProgressionDrug Screening Assays, AntitumorFluorescent DyesGenes, ReporterHumansImaging, Three-DimensionalIntravital MicroscopyIslets of LangerhansIslets of Langerhans TransplantationLuminescent ProteinsMiceMice, TransgenicAntineoplastic AgentsBacterial ProteinsFluorescent DyesLuminescent ProteinsSunitinibyellow fluorescent protein, Bacteria

Identifiers

PMID31601958
PMCPMC6787246
OpenAlexW2980236606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.